Collaborative study links cholesterol gene to malaria

09/12/2008 | American City Business Journals

Researchers said they found a link between malaria and a gene that helps control cholesterol uptake in the liver. The study -- a collaboration from Alnylam Pharmaceuticals, Germany's Cenix BioScience and Portugal's Instituto de Medicina Molecular -- could lead to malaria treatments, including RNAi-based drugs that could switch off the genes that cause the disease.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ